Kenya - English - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - artemether and lumefantrine - dispersible tablet - each uncoated tablet contains artemether 20 mg… - antimalarial antiprotozoals: aminoquinolines

Kenya - English - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - artemether lumefantrine - tablet - artemether 20mg lumefantrine 120mg - antimalarial antiprotozoals: combinations of

Kenya - English - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - efavirenz emtricitabine tenofovir disoproxil… - tablet - efavirenz 600mg emtricitabine 200mg tenofovir… - antivirals for systemic use: combinations of

Kenya - English - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - efavirenz usp - tablet - efavirenz 200mg - antivirals for systemic use: non-nucleoside

Kenya - English - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - efavirenz usp - tablet - efavirenz 600mg - antivirals for systemic use: non-nucleoside

Kenya - English - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - lamivudine usp zidovudine usp - tablet - lamivudine 150 mg & zidovudine 300 mg - antivirals for systemic use: combinations of

Kenya - English - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - tenofovir disoproxil fumarate - tablet - tenofovir disoproxil fumarate 300mg - antivirals for systemic use:

Kenya - English - Pharmacy and Poisons Board

strides pharma science limited(formerly strides… strides house, opp. iimb, - tenofovir disoproxil… - film-coated tablet - tenofovir disoproxil fumarate - 300mg/lamivudine… - lamivudine and tenofovir disoproxil

Zimbabwe - English - Medicines Control Authority

strides pharma science limited - artemether; lumefantrine - tablet; oral - 80; 480mg

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - isotretinoin, quantity: 20 mg - capsule, soft - excipient ingredients: disodium edetate; purified water; yellow beeswax; indigo carmine; butylated hydroxyanisole; brilliant scarlet 4r; dl-alpha-tocopherol; gelatin; soya oil; partially hydrogenated soya oil; glycerol; sorbitol solution (70 per cent) (non-crystallising); titanium dioxide; hydrogenated vegetable oil - treatment of severe cystic acne. a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects asssociated with its use. isotretinoin should be reversed for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.